Subjects
NAFLD, cirrhosis
CIRRHOSIS
We recruited 30 participants: 10 healthy controls, 10 patients with NAFLD, and 10 with cirrhosis. One patient in the fasting NAFLD group was excluded as we were unable to collect a biopsy. Accordingly, 29 patients were included in the analyses. The study included a screening visit and a study day with no follow‐up visits. All visits and examinations were conducted at the Copenhagen University Hospital Hvidovre.